IL2 and cancer: 3)Cytokine-Mediated Insulin Resistance: Many advanced cancer patients exhibit low-grade CRP elevation, indicative of a chronic inflammatory state, which can raise IL-2, CRP, and cortisol levels, disrupting glucose metabolism.